Author(s): Nigel Russell, Martin S. Tallman, Stuart Goldberg, Abstract: ABSSUB-4757 Session topic: 4. Acute myeloid leukemia – Clinical Background: The presence of FLT3-internal tandem duplication (ITD) in patients (pts) with acute myeloid leukemia (AML) is associated with early relapse and poor survival. Quizartinib (AC220) is an orally active inhibitor of the FLT3...
Pro zobrazení tohoto obsahu je třeba být přihlášen.